Fundacion para el Estudio de la Hematologia y Hemoterapia en Aragon Report issue

Foundation Phase 2 Phase 4

Organization Overview

First Clinical Trial
2004
NCT01124526
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now